179 related articles for article (PubMed ID: 9210684)
21. The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitis.
Wiederhold NP; Shubitz LF; Najvar LK; Jaramillo R; Olivo M; Catano G; Trinh HT; Yates CM; Schotzinger RJ; Garvey EP; Patterson TF
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437615
[TBL] [Abstract][Full Text] [Related]
22. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
[TBL] [Abstract][Full Text] [Related]
23. Antifungal susceptibility profiles of Coccidioides immitis and Coccidioides posadasii from endemic and non-endemic areas.
Ramani R; Chaturvedi V
Mycopathologia; 2007 Jun; 163(6):315-9. PubMed ID: 17484074
[TBL] [Abstract][Full Text] [Related]
24. Treatment of murine coccidioidal meningitis with fluconazole (UK 49,858).
Graybill JR; Sun SH; Ahrens J
J Med Vet Mycol; 1986 Apr; 24(2):113-9. PubMed ID: 3014105
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans.
Perfect JR; Cox GM; Dodge RK; Schell WA
Antimicrob Agents Chemother; 1996 Aug; 40(8):1910-3. PubMed ID: 8843302
[TBL] [Abstract][Full Text] [Related]
26. Itraconazole treatment of nonmeningeal coccidioidomycosis in children: two case reports and review of the literature.
Homans JD; Spencer L
Pediatr Infect Dis J; 2010 Jan; 29(1):65-7. PubMed ID: 19884875
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum.
Hata K; Kimura J; Miki H; Toyosawa T; Nakamura T; Katsu K
Antimicrob Agents Chemother; 1996 Oct; 40(10):2237-42. PubMed ID: 8891121
[TBL] [Abstract][Full Text] [Related]
28. In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.
Swinne D; Watelle M; Nolard N
Rev Iberoam Micol; 2005 Mar; 22(1):24-8. PubMed ID: 15813679
[TBL] [Abstract][Full Text] [Related]
29. In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans.
Pfaller MA; Messer SA; Hollis RJ; Jones RN
Antimicrob Agents Chemother; 2001 Oct; 45(10):2862-4. PubMed ID: 11557481
[TBL] [Abstract][Full Text] [Related]
30. In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazole.
Pfaller MA; Messer SA; Hollis RJ; Jones RN; Doern GV; Brandt ME; Hajjeh RA
Antimicrob Agents Chemother; 1998 Dec; 42(12):3242-4. PubMed ID: 9835520
[TBL] [Abstract][Full Text] [Related]
31. Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis.
Sorensen KN; Sobel RA; Clemons KV; Pappagianis D; Stevens DA; Williams PL
Antimicrob Agents Chemother; 2000 Jun; 44(6):1512-7. PubMed ID: 10817701
[TBL] [Abstract][Full Text] [Related]
32. Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations.
Tucker RM; Denning DW; Arathoon EG; Rinaldi MG; Stevens DA
J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):593-601. PubMed ID: 2170479
[TBL] [Abstract][Full Text] [Related]
33. Comparison of fluconazole and SDZ89-485 for therapy of experimental murine coccidioidomycosis.
Fierer J; Kirkland T; Finley F
Antimicrob Agents Chemother; 1990 Jan; 34(1):13-6. PubMed ID: 2327748
[TBL] [Abstract][Full Text] [Related]
34. Activity of SCH 56592 compared with those of fluconazole and itraconazole against Candida spp.
Law D; Moore CB; Denning DW
Antimicrob Agents Chemother; 1997 Oct; 41(10):2310-1. PubMed ID: 9333073
[TBL] [Abstract][Full Text] [Related]
35. A comparison of dynamic characteristics of fluconazole, itraconazole, and amphotericin B against Cryptococcus neoformans using time-kill methodology.
Burgess DS; Hastings RW
Diagn Microbiol Infect Dis; 2000 Oct; 38(2):87-93. PubMed ID: 11035239
[TBL] [Abstract][Full Text] [Related]
36. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
Espinel-Ingroff A
J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
[TBL] [Abstract][Full Text] [Related]
37. Antifungal activity of a new triazole, D0870, compared with four other antifungal agents tested against clinical isolates of Candida and Torulopsis glabrata.
Pfaller MA; Bale MJ; Buschelman B; Rhomberg P
Diagn Microbiol Infect Dis; 1994 Jun; 19(2):75-80. PubMed ID: 7805359
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and Associated Drug Exposures of Isavuconazole and Fluconazole in an Experimental Model of Coccidioidomycosis.
Kovanda LL; Sass G; Martinez M; Clemons KV; Nazik H; Kitt TM; Wiederhold N; Hope WW; Stevens DA
Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33782009
[No Abstract] [Full Text] [Related]
39. Treatment of murine coccidioidal meningitis with SCH39304.
Defaveri J; Sun SH; Graybill JR
Antimicrob Agents Chemother; 1990 Apr; 34(4):663-4. PubMed ID: 2160794
[TBL] [Abstract][Full Text] [Related]
40. In vitro activities of caspofungin, amphotericin B and azoles against Coccidioides posadasii strains from Northeast, Brazil.
Cordeiro RA; Brilhante RS; Rocha MF; Fechine MA; Costa AK; Camargo ZP; Sidrim JJ
Mycopathologia; 2006 Jan; 161(1):21-6. PubMed ID: 16389480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
